Neuralink will be able to surgically implant its device into another patient’s brain. The Wall Street Journal that the company was approved to move forward with a second procedure months after Noland Arbaugh became the to receive the brain implant.
Elon Musk last week that the company was “accepting applications for the second participant” in the trial. The company began recruiting potential participants for its first clinical trial last year with the goal of bringing the technology to people with ALS, spinal cord injuries or other conditions that cause quadriplegia.
Redefining the boundaries of human capability requires pioneers.
If you have quadriplegia and want to explore new ways of controlling your computer, we invite you to participate in our clinical trial. pic.twitter.com/svqfAkVV1M
— Neuralink (@neuralink) May 16, 2024
Neuralink has also reportedly come up with a potential fix for an issue that caused Arbaugh’s implant to malfunction about a month after his surgery. The company earlier this month that some of the implant’s threads “retracted from the brain” causing the issue. Arbaugh recently told that software updates have since restored many of those capabilities. Neuralink has shared clips of Arbaugh, who is paralyzed from the neck down, playing chess, controlling a music player app and performing other activities.
According to The Journal, Neuralink told the FDA that in a second procedure it would place the implant’s threads deeper into the patient’s brain to prevent them from moving as much as they did in Arbaugh’s case. The FDA is apparently on board with the changes. The company reportedly wants to complete the second surgery in June and has seen more than 1,000 people sign up for a chance to participate in the trial.
